Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women With Hormone Receptor Positive Breast Cancer

NCT01069211 is registered in ClinicalTrials.gov with Korean Breast Cancer Study Group as lead sponsor.

NCT NCT01069211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Lead sponsor
Korean Breast Cancer Study Group
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2010
Completion date
January 31, 2017
Enrollment
876 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer